News & Updates

Show Multimedia Only

Does COVID-19 vaccine effectiveness wane over time?

26 Nov 2021 by

A large study conducted in Israel has suggested that the effectiveness of the BNT162b2 vaccine against COVID-19 decreases over time.

26 Nov 2021

Long-term PM2.5 exposure may lead to more severe COVID-19

26 Nov 2021 by

Long-term exposure to particulate matter ≤2.5 μm (PM2.5) results in increased admission to hospital for COVID-19, according to a recent study.

26 Nov 2021

Physical activity decline may predict IPF progression

25 Nov 2021

A decline in daily physical activity (DPA) among patients with idiopathic pulmonary fibrosis (IPF) over a year is noteworthy and disproportionate to a decline in pulmonary physiology, suggests a recent study, noting that this change in DPA may be used as a prognostic tool to assess disease progression.

25 Nov 2021

Sotrovimab may reduce COVID-19 disease progression

23 Nov 2021 by

The pan-sarbecovirus monoclonal antibody sotrovimab appears to reduce the risk of COVID-19 disease progression in high-risk patients, according to interim results of the phase III COMET-ICE* trial.

23 Nov 2021

Subgroup findings boost dupilumab benefit for CRSwNP, comorbid asthma

18 Nov 2021 by

In post hoc analyses of the phase III SINUS-24 and SINUS-52 trials, the monoclonal antibody dupilumab continued to render improvements for patients with severe chronic rhinosinusitis with nasal polyps (CRSwNP), as well as among those with comorbid asthma regardless of asthma characteristics.

18 Nov 2021

Dapagliflozin in COVID-19: Outcomes consistent regardless of kidney status

17 Nov 2021 by

Secondary analysis of the DARE-19* trial presented at ASN Kidney Week 2021 has shown that the effect of dapagliflozin in patients with cardiometabolic risk factors hospitalized with COVID-19 is consistent regardless of kidney disease status.

17 Nov 2021

COVID toe: What does it tell you?

17 Nov 2021 by

New research suggests that COVID toe – a form of COVID-19–associated pernio or chilblains – may be a side effect of the immune system's response to fighting off the virus.

17 Nov 2021

Tobacco control main contributor to Hong Kong’s world-leading longevity

17 Nov 2021 by

A study led by the University of Hong Kong (HKU) has identified stringent tobacco control and resulting low smoking rates as the key reasons behind Hong Kong’s world-leading longevity.

17 Nov 2021

Aspirin shows no therapeutic potential in ARDS

16 Nov 2021

In the treatment of patients with acute respiratory distress syndrome (ARDS), the use of aspirin improves neither oxygenation index nor other physiological outcomes, according to the results of a phase II study.

16 Nov 2021

Better lung function may protect against coronary artery disease, stroke and type 2 diabetes

16 Nov 2021 by

A study by the University of Hong Kong (HKU) has revealed a causal link between better lung function and reduced risk of coronary artery disease (CAD), stroke and type 2 diabetes mellitus (T2DM).

16 Nov 2021

News & Updates

Showing Respirology articles

Showing

Specialty:

Does COVID-19 vaccine effectiveness wane over time?

Long-term PM2.5 exposure may lead to more severe COVID-19

Physical activity decline may predict IPF progression

Sotrovimab may reduce COVID-19 disease progression

Subgroup findings boost dupilumab benefit for CRSwNP, comorbid asthma

Dapagliflozin in COVID-19: Outcomes consistent regardless of kidney status

COVID toe: What does it tell you?

Tobacco control main contributor to Hong Kong’s world-leading longevity

Aspirin shows no therapeutic potential in ARDS

Better lung function may protect against coronary artery disease, stroke and type 2 diabetes